AMRHX Fees and Costs — American Growth Cannabis Fund, Class F

Data updated: 2022-12-29

The net expense ratio is 7.57%: a 1.00% management fee, a 1.00% 12b-1 fee plus 5.57% other expenses. This share class carries a deferred sales charge of up to 1.00%. Portfolio turnover was 461%.

AMRHX Fees and Expenses

Annual operating expenses and sales charges of AMRHX. Prospectus, as of November 30, 2015.

Annual operating expenses
Management fee1.00%
12b-1 fee1.00%
Other expenses5.57%
Gross expense ratio7.57%
Fee waiver—
Net expense ratio7.57%
Sales charges
Max front load0.00%
Max deferred load1.00%
Redemption fee0.00%
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

AMRHX Costs Over Time

On $10,000 invested in AMRHX, assuming 5% a year before costs, total costs come to $4,153 over 5 years, cutting the return by 7.95% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Sales charges$97$0$0
Fund expenses (net expense ratio 7.57%)$795$2,315$3,747
Lost growth on money paid in costs$0$120$406
Total costs$892$2,435$4,153
Value after costs$9,608$9,141$8,610
Impact on return, per year8.92%7.95%7.95%

AMRHX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending July 31, 2022.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 461%
  • Securities lending: none during the year

AMRHX Agency Brokers

Commissions paid.

BrokerAmountShare

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.